Clinical trial
Non-Interventional Clinical Study on Efficacy and Safety of Highly Purified Human Menopausal Gonadotrophin (HP-hMG) Menopur® Multidose in Korean Female Patients With Infertility
NCT02835469 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Interventional Clinical Study on Efficacy and Safety of Highly Purified Human Menopausal Gonadotrophin (HP-hMG) Menopur® Multidose in Korean Female Patients With Infertility
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- February 1, 2019
- Enrollment
- 412 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.